- Postoperative major bleeding risk in patients using oral antiplatelets and/or anticoagulants after laparoscopic gastric cancer surgery
-
Im C, Park YS, Min SH, Kang SH, Lee S, Lee E, Yoo M, Hwang D, Ahn SH, Suh YS, Park DJ, Kim HH
- KMID: 2539222
- Ann Surg Treat Res.
- 2023 Feb;104(2):80-89.
- doi: 10.4174/astr.2023.104.2.80
Purpose: The use of antiplatelet and/or anticoagulant therapies has become common. In rare cases, these therapies may increase the risk of dangerous postoperative bleeding. We investigated the association of antiplatelets... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
-
Hong S, Lee WJ, Park CY
- KMID: 2529215
- Endocrinol Metab.
- 2022 Apr;37(2):233-242.
- doi: 10.3803/EnM.2021.1353
Background: The role of aspirin in primary cardiovascular disease prevention in patients with diabetes remains controversial. However, some studies have suggested beneficial effects of cilostazol on cardiovascular disease in patients... -
- CITED
-
- Close
- SHARE
-
- Close
- The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction
-
Park KH, Jeong MH, Kim HK, Ki YJ, Kim SS, Ahn Y, Kook HY, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY, on behalf of the KAMIR-NIH registry investigators
- KMID: 2527299
- Korean J Intern Med.
- 2022 Mar;37(2):350-365.
- doi: 10.3904/kjim.2021.101
Background/Aims: While switching strategies of P2Y12 receptor inhibitors (RIs) have sometimes been used in acute myocardial infarction (AMI) patients, the current status of in-hospital P2Y12RI switching remains unknown. Methods: Overall, 8,476... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
-
Lee KY
- KMID: 2536935
- Cardiovasc Prev Pharmacother.
- 2021 Oct;3(4):86-94.
- doi: 10.36011/cpp.2021.3.e10
The risk of stroke recurrence is highest in the acute phase after transient ischemic attack (TIA) or ischemic stroke. Therefore, patients with TIA or ischemic stroke should be treated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Peptic Ulcer Bleeding in Patients Taking Aspirin or Anticoagulant
-
Yang HJ
- KMID: 2508873
- Korean J Gastroenterol.
- 2020 Nov;76(5):242-245.
- doi: 10.4166/kjg.2020.138
Antiplatelet and anticoagulation agents are increasingly prescribed for secondary prophylaxis in patients with cardiovascular and cerebrovascular diseases. These drugs are associated with an increased risk of gastrointestinal bleeding, including peptic... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of Antithrombotic Medication on the Risk of Chronic Subdural Hematoma Recurrence after Burr-Hole Surgery
-
Choi J, Pyen J, Cho S, Kim J, Koo Y, Whang K
- KMID: 2504646
- J Korean Neurosurg Soc.
- 2020 Jul;63(4):513-518.
- doi: 10.3340/jkns.2019.0194
Objective : Chronic subdural hematoma (CSDH) is one of the most common intracranial hemorrhages. It can be managed with a simple surgical treatment such as burr-hole trephination and drainage. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative Cessation of Both Dual Anti-Platelet Agents Is Safe after 1 Year in Patients Receiving Percutaneous Coronary Intervention
-
Lee JH, Jo SH
- KMID: 2501309
- J Lipid Atheroscler.
- 2020 May;9(2):304-312.
- doi: 10.12997/jla.2020.9.2.304
Objective: The aim of this study was to investigate the atherothrombotic and bleeding risk of discontinuing both components of dual antiplatelet therapy (DAPT) before surgery in patients with an intracoronary... -
- CITED
-
- Close
- SHARE
-
- Close
- Diffuse Alveolar Hemorrhage as a Complication of Antiplatelet Therapy after the Emergent Intra-Cranial Stent Deployment in the Hyper-Acute Ischemic Stroke
-
Kim D, Lee H, Park JJ, Roh HG, Kim HY
- KMID: 2501747
- J Korean Neurol Assoc.
- 2020 Feb;38(1):57-59.
- doi: 10.17340/jkna.2020.1.12
-
- CITED
-
- Close
- SHARE
-
- Close
- Assessment and management of coagulopathy in neurocritical care
-
Salem AM, Roh D, Kitagawa R, Choi HA, Chang TR
- KMID: 2452822
- J Neurocrit Care.
- 2019 Jun;12(1):9-19.
- doi: 10.18700/jnc.190086
Coagulopathy may be defined as the loss of balance between hemostatic and fibrinolytic processes resulting in excessive bleeding, intravascular thrombosis or abnormalities in coagulation testing. It is frequently encountered across... -
- CITED
-
- Close
- SHARE
-
- Close
- Variability of Platelet Reactivity on Antiplatelet Therapy in Neurointervention Procedure
-
Yi HJ, Hwang G, Lee BH
- KMID: 2434341
- J Korean Neurosurg Soc.
- 2019 Jan;62(1):3-9.
- doi: 10.3340/jkns.2018.0151
As more intracranial aneurysms and other cerebrovascular pathologies are treated with neurointervention procedure, thromboembolic events that frequently lead to serious neurological deficit or fatal outcomes are increasing. In order to... -
- CITED
-
- Close
- SHARE
-
- Close
- A Review of the 2018 Asia-Pacific Working Group Consensus on Non-variceal Upper Gastrointestinal Bleeding
-
Kim JS, Kim BW
- KMID: 2432431
- Korean J Gastroenterol.
- 2019 Jan;73(1):16-18.
- doi: 10.4166/kjg.2019.73.1.16
Despite recent advances in endoscopic techniques and acid-suppressive therapies, non-variceal upper gastrointestinal bleeding (NVUGIB) is still associated with significant morbidity and mortality. The increased use of dual antiplatelet agents and... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-Dose Prasugrel in Patients with Resistance to Clopidogrel for the Treatment of Cerebral Aneurysms
-
Lee D, Song Y, Han M, Park D, Suh DC
- KMID: 2424061
- Neurointervention.
- 2018 Sep;13(2):124-127.
- doi: 10.5469/neuroint.2018.01088
Thromboembolism is one of the major complications of stent assisted coiling in treatment of cerebral aneurysm. Clopidogrel resistance is so common and prasugrel is more effective in its rapid and... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
-
Oh HC, El Hajj II, Easler JJ, Watkins J, Fogel EL, McHenry L, Lehman GA, Choi JS, Kang H, Sherman S
- KMID: 2429077
- Gut Liver.
- 2018 Mar;12(2):214-218.
- doi: 10.5009/gnl17204
BACKGROUND/AIMS: This study aimed to determine the risk of post-endoscopic retrograde cholangiopancreatography (post-ERCP) bleeding among patients taking antiplatelet agents (APAs), particularly in the era of multiple APAs. METHODS: The primary outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- Stent-Assisted Coil Embolization Using Only a Glycoprotein IIb/IIIa Inhibitor (Tirofiban) for Ruptured Wide-Necked Aneurysm Repair
-
Lee SH, Park IS, Lee JM, Lee K, Park H, Lee CH
- KMID: 2422555
- J Cerebrovasc Endovasc Neurosurg.
- 2018 Mar;20(1):14-23.
- doi: 10.7461/jcen.2018.20.1.14
OBJECTIVE: The aim of this study was to evaluate the safety and efficacy of stent-assisted coil embolization using only a glycoprotein IIb/IIIa inhibitor (tirofiban). MATERIALS AND METHODS: We retrospectively reviewed patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Clopidogrel Response Variability in Unruptured Intracranial Aneurysm Patients Treated with Stent-Assisted Endovascular Coil Embolization : Is Follow-Up Clopidogrel Response Test Necessary?
-
Kim MS, Park ES, Park JB, Lyo IU, Sim HB, Kwon SC
- KMID: 2408021
- J Korean Neurosurg Soc.
- 2018 Mar;61(2):201-211.
- doi: 10.3340/jkns.2017.0303.009
OBJECTIVE: The purpose of this study was to analyze the variability of clopidogrel responses according to duration of a clopidogrel drug regimen after stent-assisted coil embolization (SAC), and to determine... -
- CITED
-
- Close
- SHARE
-
- Close
- Stent thrombosis and optimal duration of dual antiplatelet therapy after coronary stenting in contemporary practice
-
Cho MS, Park DW
- KMID: 2411477
- Korean J Intern Med.
- 2017 Sep;32(5):769-779.
- doi: 10.3904/kjim.2016.391
The introduction of drug-eluting stents (DES) in the practice of percutaneous coronary intervention (PCI) has substantially reduced angiographic and clinical restenosis but is associated with an increasing propensity for very... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of Rapidrhino® Packing in Patients Who Visited Emergency Room due to Anterior Epistaxis
-
Kim B, Kwon MO, Yang CJ, Cho IS, Lee KI
- KMID: 2386576
- J Korean Soc Emerg Med.
- 2017 Jun;28(3):248-254.
- doi: 10.0000/jksem.2017.28.3.248
PURPOSE: Although there are many treatment options for managing epistaxis, little is known about their outcomes in the emergency department (ED). In this study, we evaluated the management of epistaxis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
-
Park Y, Kim KH, Kang MG, Ahn JH, Jang JY, Park HW, Koh JS, Park JR, Hwang SJ, Jeong YH, Hwang JY, Lee HR, Kwak CH
- KMID: 2385391
- Korean Circ J.
- 2017 May;47(3):366-376.
- doi: 10.4070/kcj.2016.0384
BACKGROUND AND OBJECTIVES: Combination antiplatelet therapy reduces the risk of ischemic stroke compared with aspirin monotherapy in non-valvular atrial fibrillation (NVAF) patients. The underlying mechanism, however, remains unclear. In addition,... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Hemorrhage Attributed to Underlying Chronic Diseases and Uninterrupted Aspirin Therapy of Patients Undergoing Minor Oral Surgical Procedures: A Retrospective Cohort Study
-
Rojanaworarit C, Limsawan S
- KMID: 2384528
- J Prev Med Public Health.
- 2017 May;50(3):165-176.
- doi: 10.3961/jpmph.16.121
OBJECTIVES: This study aimed to estimate the risk of bleeding following minor oral surgical procedures and uninterrupted aspirin therapy in high-risk patients or patients with existing chronic diseases compared to... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent advances in ischemic stroke management
-
Yoon CW, Rha JH
- KMID: 2391516
- J Korean Med Assoc.
- 2016 Oct;59(10):775-784.
- doi: 10.5124/jkma.2016.59.10.775
There have been recent advances in the hyperacute treatment and secondary prevention of ischemic stroke. Thrombolysis with intravenous tissue plasminogen activator has been approved for a 3 to 4.5 hour... -
- CITED
-
- Close
- SHARE
-
- Close
